American Association of Clinical Endocrinology Communities Middle East & North Africa 2025 Original price was: $240.00.$165.00Current price is: $165.00.
Sale!
American Association of Clinical Endocrinology Communities Middle East & North Africa 2025
$ 40.50
+Shipping: $9.90 per carton — Free when you order 2+ cartons!- Description Include: 56 videos 56 file sub vtt 54 pdfs, size: 23.46 GB Target Audience: endocrinologists and primary care physicians Sample video: contact me for sample video Information: 1. Overview The American Association of Clinical Endocrinology Communities Middle East & North Africa 2025 program provides a comprehensive review of the latest advancements in endocrinology. It covers critical updates in diabetes management technologies, obesity pharmacotherapy, thyroid cancer, menopause, and bone health, with special clinical considerations for regional practices such as managing patients during Ramadan. The three-day event provided a platform for regional and international endocrinology leaders to collaborate and discuss advancements in diabetes, thyroid, bone, pituitary, adrenal, and metabolic health. It featured over 50 educational sessions and hands-on workshops tailored to the unique clinical challenges of the MENA region. Course Date: November 21–23, 2025, at the InterContinental Dubai Festival City, United Arab Emirates 2. Learning Objectives By the end of the meeting, you will be able to: Demonstrate the understanding of a multidisciplinary approach, including lifestyle and nutrition in the effective management of metabolic diseases. Gain insight and skills in implementation of self-management tools, new medications, AI and technology for improved outcomes in Diabetes. Demonstrate appreciation and understanding of bone mineral disorders. Explore the latest clinical guidelines for thyroid nodules and cancer, and engage in case-based learning of complex thyroid issues. Review and apply evidence-based strategies for assessment and management of pituitary and adrenal conditions. Integrate multidisciplinary approaches for improved care and treatment of endocrine disorders. Evaluate, understand, and manage women’s health and menopause. 3. Target Audience Best for endocrinologists and primary care physicians who want updates on diabetes management, obesity therapies, and thyroid disorders. 4. Topics Closing Remarks IDS1.A.1 CGM Use in People With and Without Diabetes IDS1.A.2 SGLT2i Use in Type 1 DM IDS1.A.3 GLP1 use in T1DM IDS1.B.1 Menopause Hormone Therapy 101 IDS1.B.2 Mood, Sleep and Cognitive Function in Menopause IDS1.B.3 Menopause and Cardiometabolic Risk IDS1.C.1 Molecular Basis of Thyroid Cancer and its Translational Implications IDS1.C.2 What’s New in Medullary Thyroid Cancer IDS1.C.3 Contemporary Management of Graves’ Disease IDS2.A.1 Diabetes and Ramadan An Update IDS2.A.2 Thyroid and Ramadan In Health and Disease IDS2.A.3 Adrenal Replacement in Ramadan IDS2.B.1 Obesity Management in Adolescent IDS2.B.2 From Fat Storage to Fat Burning Exploring the Role of Fasting in Obesity Treatment IDS2.B.3 Approaching Weight Management in Women of Childbearing Age IDS2.C.1 Smoking and Bone Health IDS2.C.2 Osteoporosis in Men IDS2.C.3 Bone Health in Cancer Patients IDS2.D.1 Diabetes Management in the Older Adult IDS2.D.2 Obesity Management in the Elderly IDS2.D.3 When to Treat and When Not to Treat for Thyroid Disease in Geriatrics IDS3.A.1 Mild Autonomous Cortisol Secretion MACS IDS3.A.2 Adrenocortical Cancer New Advances IDS3.A.3 Regional Barriers to Diagnosis and Management of Adrenal Insufficiency IDS3.B.1 Obesity Management in Persons with Special Needs IDS3.B.2 Metabolic and Bariatric Management in Pediatrics IDS3.B.3 Turners Syndrome MTE1.A What’s New in the Approach and Management of Pheochromocytoma Paraganglioma MTE1.B Pituitary Tumors, Biology and Clinical Classification MTE1.C Treatment of Osteoporosis in the Oldest Old MTE2.A Prevention and Cure, Current and Future for Type 1 Diabetes MTE2.B Management of Kidney Disease in Diabetes – An Update MTE2.C Endocrine Practice in Resource – Limited Settings MTE3.A Screening & Management of Metabolic Liver Disease in Endocrine Clinics MTE3.B What is in the Pipeline for Diabetes and Obesity Management MTE3.C Islet Cell Transplant, Innovations in Type 1 Diabetes Management MTE3.D Remission of T2D Through Diet – Is it Real MTE4.ASurgicalHypoparathyroidism MTE4.B Thyroid Autoimmunity and Cardiovascular Risk Beyond Hypothyroidism MTE4.C Beyond BMI The Role of Body Composition Assessment in Obesity Pharmacotherapy MTE4.D Testosterone Replacement – Indications and Challenges MTE5.A Primary Aldosteronism MTE5.B What is the Role for Lifestyle Support in the New Era of Medical Treatment for Obesity MTE5.C Parathyroid in Pregnancy PL1. Acromegaly, Diagnosis, Management and Anomalies PL2. Understanding Sexual Dysfunction in Women with Obesity and Diabetes PL3. Updated Thyroid Nodule and Cancer Guidelines, An Endocrine Surgeon’s Perspective PL4. Indications for SGLT2I and Incretin-Based Therapy Beyond Diabetes Overview and Future Outlook PL5. Congenital Adrenal Hyperplasia PL6. Diagnosis and Management of Hypoparathyroidism PL7. Breaking the Cycle From Fat Cells and Gut to the Mind in Weight Regain Roundtable Discussion – Ali Alzahrani Roundtable Discussion – Samer El-Kaissi Roundtable Discussion – Tamer Elsherbiny Welcome and Opening Ceremony
Related products
-
Sale!
-
Sale!
-
Sale!
-
Sale!
